Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...

Assembly Biosciences, Inc.'s ABI-5366 showed strong interim phase 1b results in HSV-2 recurrent genital herpes patients.

Growing research shows common herpes viruses may raise dementia risk, challenging previous skepticism and opening new paths ...

Assembly Biosciences ( NASDAQ: ASMB) reported promising results from an early stage study of its experimental candidate, ...

A modified herpes virus (RP1) combined with immunotherapy showed promising results against advanced melanoma in a clinical ...

Many young adults make the choice to hook up and have sex in college, but they’re not always educated about how to prevent ...

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., (“Company” or “Adolore”) announced that ...

Raipur: The state viral research and diagnostic laboratory (VRDL) at the All India Institute of Medical Sciences (AIIMS), ...

A 56-year-old woman with a history of relapsed/refractory IgG kappa multiple myeloma presented with a 3-day history of right ...